The Bulgarian Drug Agency issued a marketing authorisation for the medicinal product Cisaxa 2mg/ml injection/ infusion solution. The medicine is a neuromuscular blocking agent with average duration of action for intravenous administration with quantitative composition cisatracurium 2 mg (as cisatracurium besilate 2.68 mg per 1 ml).

Cisaxa should be used during surgical and other procedures and in intensive care ward for adults and children above 1 month; it can be used as a general anesthesia accompanying agent.

ATC code: M03AC11